EP Working Group on Access to Medicines and Poverty-Related Diseases

EP Working Group on Access to Medicines and Poverty-Related Diseases Putting Patient's Needs First: Supporting better innovation, access to medicines and healthcare to combat poverty-related diseases

The European Union has a major impact on access to medicines for developing countries, through its policies, legislation and bilateral and regional trade agreements. It is vital that the EU adopts appropriate measures that improve access to existing medical tools (medicines, diagnostics, vaccines) and that stimulate the research and development (R&D) of urgently-needed better tools for people in developing countries, notably for poverty-related diseases such as HIV/AIDS, tuberculosis and malaria. The Working Group operates as a Bureau of MEPs, with one Chair (David Martin - S&D) and four Co-Chairs (Kader Arif - S&D, Niccoló Rinaldi – ALDE, Carl Schlyter – Greens/EFA, Eleni Theocharous - EPP), and a Secretariat, formed by Médecins Sans Frontières’ Campaign for Access to Essential Medicines and Global Health Advocates. The Working Group is open to MEPs, academics, representatives from the European Commission, international organisations and civil society.

Adres

Brussels

Telefoon

0032.2893.10.51

Website

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer EP Working Group on Access to Medicines and Poverty-Related Diseases nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Snelkoppelingen

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Type